晶泰控股-P(02228.HK):聯交所批準公司爲已商業化公司 簡稱將不再印有“P”標記
格隆匯4月6日丨晶泰控股-P(02228.HK)發佈公告,公司已獲聯交所批準,公司將不再被視爲未商業化公司,而將被視爲已商業化公司。
獲批準後,公司的英文及中文股份簡稱將不再印有“P”標記。公司股份將以新英文股份簡稱“XTALPI”及中文股份簡稱“晶泰控股”於聯交所買賣,取代現有英文股份簡稱“XTALPI-P”及中文股份簡稱“晶泰控股-P”,自2025年4月9日上午九時正起生效。公司的股份代號“2228”將維持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.